Literature DB >> 11428445

The chronic indwelling catheter and urinary infection in long-term-care facility residents.

L E Nicolle1.   

Abstract

From 5% to 10% of residents of long-term-care facilities have urinary drainage managed with chronic indwelling catheters. These residents are always bacteriuric, usually with a complex microbiological flora of two to five organisms and a biofilm on the catheter that may contribute to obstruction. Residents with chronic indwelling catheters have increased morbidity from urinary infection compared to bacteriuric residents without chronic catheters. The most effective means to prevent infection is limitation of chronic indwelling catheter use. While appropriate catheter care and infection control precautions are recommended in managing these patients, the impact of these practices on the occurrence of urinary infection or prevention of symptomatic episodes has not been evaluated. Symptomatic infection can likely be prevented by attention to catheter care, including early recognition and replacement of obstructed catheters and prevention of catheter trauma. Appropriate use of prophylactic antimicrobial therapy prior to invasive genitourinary procedures is also necessary. Asymptomatic bacteriuria should not be treated. When symptomatic episodes occur, patients should be evaluated clinically and microbiologically and treated with appropriate antimicrobial therapy. Further technological advances in catheter material and urine drainage will be needed to have a substantial impact on the frequency of urinary infection with chronic catheter use.

Entities:  

Mesh:

Year:  2001        PMID: 11428445     DOI: 10.1086/501908

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  25 in total

1.  [Bladder catheterization in nursing care. An unresolved problem! Initiative to build a guideline].

Authors:  B Liedl; J Gleissner; B Göckel-Beining; H J Knopf; I Kopp; S Lenk; K Naber; C Tschuschke; H J Piechota
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

2.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 3.  Catheter-related urinary tract infection: practical management in the elderly.

Authors:  Lindsay E Nicolle
Journal:  Drugs Aging       Date:  2014-01       Impact factor: 3.923

4.  Antimicrobial prescribing in nursing homes in Finland: results of three point prevalence surveys.

Authors:  M-L Rummukainen; T Kärki; M Kanerva; M Haapasaari; J Ollgren; O Lyytikäinen
Journal:  Infection       Date:  2012-09-17       Impact factor: 3.553

Review 5.  A scoping review of important urinary catheter induced complications.

Authors:  K H Dellimore; A R Helyer; S E Franklin
Journal:  J Mater Sci Mater Med       Date:  2013-05-10       Impact factor: 3.896

6.  EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice.

Authors:  Ana L Flores-Mireles; Jerome S Pinkner; Michael G Caparon; Scott J Hultgren
Journal:  Sci Transl Med       Date:  2014-09-17       Impact factor: 17.956

Review 7.  Catheter-related urinary tract infection.

Authors:  Lindsay E Nicolle
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

8.  Ureolytic Biomineralization Reduces Proteus mirabilis Biofilm Susceptibility to Ciprofloxacin.

Authors:  Xiaobao Li; Nanxi Lu; Hannah R Brady; Aaron I Packman
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

9.  Complicated urinary tract infection in adults.

Authors:  L E Nicolle
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

10.  The design of the SAFE or SORRY? study: a cluster randomised trial on the development and testing of an evidence based inpatient safety program for the prevention of adverse events.

Authors:  Betsie G I van Gaal; Lisette Schoonhoven; Marlies E J L Hulscher; Joke A J Mintjes; George F Borm; Raymond T C M Koopmans; Theo van Achterberg
Journal:  BMC Health Serv Res       Date:  2009-04-01       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.